Life Science Company News

Reset
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Apellis Pharmaceuticals, Inc.

CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience

Read more ››
By: GlobeNewswire - 23 Apr 2024

KFSH&RC Announced as Strategic Partner for the Saudi American Healthcare Forum 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  King Faisal Specialist Hospital & Research Centre

Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Lisata Therapeutics, Inc.

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Kiniksa Pharmaceuticals Corp.

Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive Vice President and Head of Research and Development, and Strengthens Scientific Advisory Board with the Addition of Dr. Ad

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Recludix Pharma

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Unity Biotechnology Inc

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Werewolf Therapeutics, Inc.

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Madrigal Pharmaceuticals, Inc.

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  LifeMD, Inc

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Rezolute, Inc.

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  EDAP TMS S.A.

DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  DiagnaMed Holdings Corp.

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  PROCEPT BioRobotics Corporation

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  INmune Bio Inc.

PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  PDS Biotechnology Corporation

Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Tome Biosciences

OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  OncoC4, Inc.

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Daré Bioscience, Inc.

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  BiomX Inc.
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »